thank stand welcome second quarter company earn conference call time participant listen mode speaker presentation question answer session operator instruction pleasure introduce vice president investor relation risk management vice president investor relation risk management good afternoon welcome company second quarter earn conference call today call result guidance include earn release remain time presenter today call white president chief executive officer chief financial officer treasurer begin like remind conference call contain forward look statement include revenue earn share guidance statement regard anticipate result operation market regulatory condition integration acquisition failure achieve anticipate benefit forward look statement depend assumption data method incorrect imprecise subject risk uncertainty event could cause actual result future action company differ materially describe forward look statement forth caption forward look statement today earn release describe file include form form file available website cooperco additional question follow call please call investor line email cooperco turn call open remark white president chief executive officer great thank welcome everyone company fiscal second quarter conference call happy report post time record quarterly revenue drive record quarterly earn business rebound nicely silicone hydrogel lens myopia management lead fertility drive quarter report percentage constant currency basis consolidate revenue million million million earn share grow clariti lead strongest part region allow rebound quickly strongly offset challenge market still face significant restriction still nice momentum look forward back school season grow quarter lead strength contact lens company obviously index region impact temper market performance execute high level take share offset challenge region leader quite time stronger success account really look forward rebound consumer activity definitely benefit lastly lead strength clariti make progress rebound slow many country include strong presence nevertheless similar execute high level take share help offset market challenge overall give geographic extremely happy performance expect remain healthy vaccine roll around world consumer activity improve move detail silicone hydrogel daily grow clariti post strong result particular take share lead improve availability especially toric market perspective still roughly billion annual global sale older daily hydrogel expect trade silicone come year tailwind significant positive index daily great performance clariti move portfolio solid growth around world lead particular energy unique innovative lens digital zone optic help alleviate fatigue excessive screen time market lead toric multifocal post extremely strong result also announce double number prescription option toric provide context significant toric prescribe toric lens world available prescription option monthly silicone hydrogel toric lens combine regard product launch remain incredibly active clariti second base curve sphere roll toric toric multifocal extend toric range clariti continue roll around world happy multifocal launch list start seed select country come month full launch plan late calendar year part prelaunch activity complete product test eight country thousand patient excite response absolutely fantastic huge surprise give extremely strong clinical data success sphere toric still great multifocal category roughly billion global contact lens market roughly half daily give currently index daily segment roughly share believe multifocal successful move myopia management portfolio grow quarter million within grow million ortho grow million global leader myopia management space portfolio broadest industry comprise approve myopia control product broad range market lead ortho lens innovative vision give strength expect portfolio reach million sale year exceed million next year regard make fantastic progress account enter multiple pilot program retailer group around world momentum accelerate include sale grow sequentially launch south great market thing hold back grow even faster restriction several important country regardless make tremendous progress expect strong growth move forward perspective average wearer remain compare regular contact lens wearer show treatment bring contact lens much younger additionally multiple professional association recommend myopia management standard care include world council university educational train course curriculum regard ortho great quarter drive broad product portfolio halo effect start myopia management market develop value offer multiple option care professional help ortho franchise also believe benefit myopia management schedule launch multiple market prior calendar year respect receive year clinical data process submit approval myopia management treatment take three year data approval receive approval faster give strong data glass rather contact lens meantime finish legal regulatory work close joint venture remain excite potential partnership wrap myopia management actively invest sale market launch regulatory approval keep drive success focus remain lead clinical data provide best broadest portfolio market conclude vision rollout vaccine definitely benefit give consumer nature business plenty opportunity head strong back school season gear great presentation meet several upcoming care conference longer term basis macro growth trend remain solid roughly third world myopic today number expect increase give robust portfolio product launch momentum myopia management strong data great shape long term sustainable growth move outstanding quarter record revenue million three focus area fertility office surgical medical device outperform start fertility revenue grow year year million easily become best fertility quarter ever strength around world throughout product portfolio take share position future gain improve traction several market account strategy create opportunity capitalize market lead portfolio product service cover full spectrum clinic need outside pharma offer strong growth consumable product like medium witness proprietary automate management system clinic implement maximize safety security optimize practice benefit increase utilization artificial intelligence base genetic test platform increase doctor ability select best embryo transfer also capital equipment business growth product like incubator market perspective still negatively impact patient flow many country combination share gain healthy patient flow part drive result overall increase vaccination activity continue support recovery industry patient able return clinic increase maternal better access treatment trend continue support strong growth many year come within office surgical unit grow office surgical medical device perform really positive health wellness trend continue drive patient activity hormone free market product offer fantastic long last birth control address need interest woman look healthy alternative within medical device several product perform include advance direct visualization system evaluation endometrium portfolio uterine conclude excellent quarter reopen activity capital equipment sale tough forecast note guidance expect continue deliver strong result similar vision powerful macro trend support growth exposure consumer activity benefit economy around world reopen finish release report week like passionate environmental sustainability social responsibility good governance great summary stand today insight future effort excellent position look forward continue advancement provide additional update future turn call chief financial officer treasurer thank good afternoon everyone commentary basis please refer earn release reconciliation result second quarter consolidate revenue increase year year constant currency million consolidate gross margin increase year year improvement drive strength higher margin business lead nice improvement fertility margin positive impact transfer significant amount production also post improve margin drive currency product move forward excellent shape continue deliver solid gross margin complete largest part capital expansion project expect receive benefit time capacity utilization increase opex year year expense naturally increase rebound revenue along higher sale market expense associate investment area myopia management expense keep control result consolidate operate margin last year interest expense million lower interest rate lower average debt level effective rate drive benefit option exercise roughly million average share outstanding free cash flow solid million comprise million operate cash flow offset million capex debt decrease billion adjust leverage ratio decrease time drive lower debt improve move guidance worth note acquire business since last report earn first contact lens base contact lens manufacturer primarily focus specialty lens include ortho annual revenue roughly million purchase roughly million second medical base medical device company develop market suite differentiate woman health medical device integrate lead illumination medical roughly million annual revenue purchase million deal highly strategic perfectly respectively move guidance continue monitor evaluate scope duration impact ongoing pandemic operation financial result still view risk factor visibility sufficient allow provide follow update fiscal guidance consolidate revenue expect range billion billion constant currency revenue billion billion constant currency revenue million million constant currency expect range provide color range gross margin expectation unchanged expect improve manufacture efficiency offset moderate margin pressure grow daily surgical continue post strong result expect opex percent revenue track higher first half year lead sale market investment support reopen activity ongoing support myopia management give lower rate expect full year rate around lastly move primarily expect improvement offset negative impact wrap guidance business continue strengthen expect free cash flow exceed million year hand back operator question